Silvercrest Asset Management’s Pediatrix Medical MD Stock Holding History

Silvercrest Asset Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.1M	Sell	912,380 -58,230	-6%	-$1.32M	0.15%	189
2026 Q1	$20.8M	Sell	970,610 -61,741	-6%	-$1.29M	0.15%	183
2025 Q4	$22.1M	Buy	+1,032,351	New	+$21.2M	0.15%	182
2017 Q1	–	Sell	-4,390	Closed	-$293K	–	586
2016 Q4	$293K	Hold	4,390	–	–	﹤0.01%	489
2016 Q3	$291K	Hold	4,390	–	–	﹤0.01%	472
2016 Q2	$318K	Hold	4,390	–	–	﹤0.01%	468
2016 Q1	$283K	Hold	4,390	–	–	﹤0.01%	470
2015 Q4	$315K	Hold	4,390	–	–	﹤0.01%	477
2015 Q3	$337K	Sell	4,390 -2,000	-31%	-$161K	0.01%	407
2015 Q2	$474K	Buy	6,390 +390	+7%	+$28.1K	0.01%	405
2015 Q1	$435K	Hold	6,000	–	–	0.01%	383
2014 Q4	$397K	Hold	6,000	–	–	0.01%	385
2014 Q3	$329K	Hold	6,000	–	–	0.01%	395
2014 Q2	$349K	Hold	6,000	–	–	0.01%	393
2014 Q1	$372K	Hold	6,000	–	–	0.01%	372
2013 Q4	$320K	Hold	6,000	–	–	0.01%	387
2013 Q3	$301K	Hold	6,000	–	–	0.01%	384
2013 Q2	$275K	Buy	+6,000	New	+$269K	0.01%	383

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Silvercrest Asset Management's MD Position: Q2 2026 in Review

Silvercrest Asset Management reduced its Pediatrix Medical (MD) stake by 6% in Q2 2026, selling an estimated $1.32M and leaving 912,380 shares worth $23.1M. The position accounts for 0.15% of the portfolio, ranked #189.

Silvercrest Asset Management first reported a position in MD in Q2 2013 and has held it in 18 quarters since. 305 funds tracked by Wall St. Rank hold MD as of Q2 2026.

Silvercrest Asset Management held 912,380 shares of Pediatrix Medical worth $23.1M as of Q2 2026.
Silvercrest Asset Management sold 58,230 Pediatrix Medical shares in Q2 2026, an estimated $1.32M.
Pediatrix Medical made up 0.15% of Silvercrest Asset Management's portfolio in Q2 2026, its #189 holding.
Silvercrest Asset Management first reported a position in Pediatrix Medical in Q2 2013 and has held it in 18 quarters since.
305 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.